Neola Medical AB (publ) (STO:NEOLA)
Sweden
· Delayed Price · Currency is SEK 0.880
0.00 (0.00%)
Mar 5, 2026, 4:26 PM CET
Neola Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 | Upgrade
|
| Cash & Short-Term Investments | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 | Upgrade
|
| Cash Growth | -17.55% | -9.38% | -46.17% | 74.76% | 37.80% | Upgrade
|
| Accounts Receivable | 1.11 | - | - | - | - | Upgrade
|
| Other Receivables | - | 1.07 | 20.9 | 1.02 | 1.45 | Upgrade
|
| Receivables | 1.11 | 1.07 | 20.9 | 1.02 | 1.45 | Upgrade
|
| Prepaid Expenses | - | 0.42 | 0.63 | 0.49 | 0.4 | Upgrade
|
| Other Current Assets | - | - | - | -0 | - | Upgrade
|
| Total Current Assets | 17.24 | 21.04 | 43.11 | 41.6 | 24.79 | Upgrade
|
| Property, Plant & Equipment | 0.22 | 0.2 | 0.14 | 0.22 | 0.16 | Upgrade
|
| Long-Term Deferred Charges | 61.22 | 52.37 | 42.78 | 33.51 | 18.88 | Upgrade
|
| Other Long-Term Assets | 0.13 | - | - | - | 0 | Upgrade
|
| Total Assets | 78.8 | 73.61 | 86.02 | 75.33 | 43.83 | Upgrade
|
| Accounts Payable | - | 1.07 | 2.18 | 1.49 | 1.3 | Upgrade
|
| Accrued Expenses | 1.56 | 2 | 1.62 | 1.79 | 1.44 | Upgrade
|
| Current Income Taxes Payable | - | 0.1 | 0.09 | 0.08 | 0.05 | Upgrade
|
| Other Current Liabilities | 1.44 | 1.49 | 2.27 | 1.98 | 0.41 | Upgrade
|
| Total Current Liabilities | 3 | 4.65 | 6.16 | 5.35 | 3.19 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.83 | 2.5 | - | Upgrade
|
| Total Liabilities | 3 | 4.65 | 6.99 | 7.85 | 3.19 | Upgrade
|
| Common Stock | 75.8 | 5.01 | 3.98 | 3.98 | 1.5 | Upgrade
|
| Additional Paid-In Capital | - | 99.08 | 80.11 | 79.56 | 44.83 | Upgrade
|
| Retained Earnings | - | -35.13 | -25.06 | -16.05 | -5.7 | Upgrade
|
| Comprehensive Income & Other | - | - | 20 | - | - | Upgrade
|
| Shareholders' Equity | 75.8 | 68.96 | 79.03 | 67.49 | 40.63 | Upgrade
|
| Total Liabilities & Equity | 78.8 | 73.61 | 86.02 | 75.33 | 43.83 | Upgrade
|
| Net Cash (Debt) | 16.12 | 19.56 | 21.58 | 40.09 | 22.94 | Upgrade
|
| Net Cash Growth | -17.55% | -9.38% | -46.17% | 74.76% | 37.80% | Upgrade
|
| Net Cash Per Share | 0.21 | 0.28 | 0.39 | 1.54 | 1.64 | Upgrade
|
| Filing Date Shares Outstanding | 77.95 | 70.15 | 70.15 | 55.69 | 21.05 | Upgrade
|
| Total Common Shares Outstanding | 77.95 | 70.15 | 55.69 | 55.69 | 21.05 | Upgrade
|
| Working Capital | 14.24 | 16.39 | 36.95 | 36.26 | 21.59 | Upgrade
|
| Book Value Per Share | 0.97 | 0.98 | 1.42 | 1.21 | 1.93 | Upgrade
|
| Tangible Book Value | 75.8 | 68.96 | 79.03 | 67.49 | 40.63 | Upgrade
|
| Tangible Book Value Per Share | 0.97 | 0.98 | 1.42 | 1.21 | 1.93 | Upgrade
|
| Machinery | - | 0.46 | 0.31 | 0.31 | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.